NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

肝素市場:全球產業趨勢,佔有率,規模,成長,機會及預測(2021∼2026年)

Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版商 IMARC Services Private Limited 商品編碼 1007181
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
肝素市場:全球產業趨勢,佔有率,規模,成長,機會及預測(2021∼2026年) Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026
出版日期: 2021年05月20日內容資訊: 英文
簡介

全球肝素的市場規模,2020年達到了67億美元。深靜脈血栓形成 (DVT) 和肺栓塞 (PE) 等各種醫療疾病的患病率不斷上升,是推動全球市場發展的關鍵因素之一。此外,肝素已被證明是治療靜脈血栓栓塞和心血管疾病 (CVD) 的極其有效的藥物,這對其市場成長出了重大貢獻。改善醫療保健設施的政府資金和廣泛的研發 (R&D) 活動增加,以開發用於化學療法的超低分子量肝素,也為市場創造了積極的前景。

本報告提供肝素市場相關調查,市場概要,以及各產品,各來源,各投藥法,各用途,各終端用戶,各流通管道,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 序文

第2章 範圍與調查手法

第3章 摘要整理

第4章 簡介

第5章 全球肝素市場

  • 市場概要
  • 市場成果
  • COVID-19的影響
  • 各產品的市場區隔
  • 各來源的市場區隔
  • 各投藥法的市場區隔
  • 各用途的市場區隔
  • 各終端用戶的市場區隔
  • 各流通管道的市場區隔
  • 各地區的市場區隔

第6章 市場區隔,各產品

  • 未分級肝素
  • 低分子肝素(LMWH)
  • 超低分子肝素(ULMWH)

第7章 市場區隔,各來源

第8章 市場區隔,各投藥法

  • 口服
  • 非口服

第9章 市場區隔,各用途

  • 心房纖維顫動和心臟病發作
  • 中風
  • 深部靜脈血栓症(DVT)
  • 肺動脈栓塞(PE)
  • 其他

第10章 市場區隔,各終端用戶

  • 醫院
  • 診所
  • 家庭看護設定
  • 門診病人手術中心
  • 其他

第11章 市場區隔,各流通管道

  • 醫院藥局
  • 零售藥局
  • 藥妝店
  • 網路商店
  • 其他

第12章 市場區隔,各地區

  • 歐洲
  • 北美
  • 亞太地區
  • 中東和非洲
  • 南美

第13章 SWOT分析

第14章 價值鏈分析

第15章 波特的五力分析

第16章 價格分析

第17章 競爭情形

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • GlaxoSmithKline
    • Hepalink
    • Pfizer
    • LeoPharma
    • Sanofi
    • Dr. Reddy's Laboratories
    • Teva Pharmaceutical Industries
    • Aspen
    • LEO Pharma
    • Baxter
    • Changshan Pharm
    • Sandoz
    • Opocrin
    • Deebio
    • Tiandong
目錄
Product Code: SR1020C267_Report

The global heparin market reached a value of US$ 6.7 Billion in 2020. Heparin, denoted by the chemical formula C12H19NO20S3, is a sulfur-containing polysaccharide that acts as an anticoagulant or a blood thinner. It prevents the formation of blood clots inside blood vessels and is used for the treatment of heart conditions and unstable angina. It is also used in post-surgeries as well as during dialysis and blood transfusion. Heparin is usually injected directly into the muscle or the veins to break up clots and maintain smooth fluidity of the blood. Some common side-effects of using heparin include easy bruising and itchy skin with redness.

The rising prevalence of various medical ailments such as deep vein thrombosis (DVT) and pulmonary embolism (PE) is one of the key factors driving the global market. Also, heparin has been proven to be an extremely effective drug for venous thromboembolism and cardiovascular disorders (CVDs), which is contributing significantly to its market growth. Furthermore, biopharmaceutical companies are developing innovative medicines to enhance the therapeutic potential of heparin and reduce its side-effects. Availability of synthetic and semi-synthetic heparin mimetics that assist in treating various cancers, coagulation and inflammatory diseases is significantly increasing the adoption of the product. The market is further driven by the various advancements in the field of carbohydrate synthesis, which include building block preparation, coupling reactions and the development of convergent strategies. Moreover, increasing government funding toward improving healthcare facilities and extensive research and development (R&D) activities to develop heparin with ultra-low molecular weight for utilization in chemotherapy are also creating a positive outlook for the market.

IMARC Group's latest report provides a deep insight into the global heparin market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the heparin market in any manner. Looking forward, IMARC Group expects the global heparin market to exhibit steady growth during the next five years.

Report Coverage:

  • Historical, Current and Future Market Trends

Market Breakup by Product:

  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-low Molecular Weight Heparin (ULMWH)

Market Breakup by Source:

  • Bovine
  • Porcine

Market Breakup by Mode of Administration:

  • Oral
  • Parenteral

Market Breakup by Application:

  • Atrial Fibrillation & Heart Attack
  • Stroke
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Others

Market Breakup by End-User:

  • Hospitals
  • Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Others

Market Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Stores
  • Others

Market Breakup by Region:

  • Europe
  • North America
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Competitive Landscape:

  • The report has also analyzed the competitive landscape of the market with some of the key players being GlaxoSmithKline, Hepalink, Pfizer, LeoPharma, Sanofi, Dr. Reddy's Laboratories, Teva Pharmaceutical Industries, Aspen, LEO Pharma, Baxter, Changshan Pharm, Sandoz, Opocrin, Deebio, Tiandong, etc.

Key Questions Answered in This Report:

  • How has the global heparin market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global heparin industry?
  • What are the key regional markets in the global heparin industry?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the source?
  • What is the breakup of the market based on the mode of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the global heparin industry?
  • What are the key driving factors and challenges in the global heparin industry?
  • What is the structure of the global heparin industry and who are the key players?
  • What is the degree of competition in the global heparin industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market ...Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Heparin Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Product
  • 5.5 Market Breakup by Source
  • 5.6 Market Breakup by Mode of Administration
  • 5.7 Market Breakup by Application
  • 5.8 Market Breakup by End-User
  • 5.9 Market Breakup by Distribution Channel
  • 5.10 Market Breakup by Region
  • 5.11 Market Forecast

6 Market Breakup by Product

  • 6.1 Unfractionated Heparin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Low Molecular Weight Heparin (LMWH)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Ultra-Low Molecular Weight Heparin (ULMWH)
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Source

  • 7.1 Bovine
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Porcine
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Mode of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Parenteral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Atrial Fibrillation & Heart Attack
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stroke
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Deep Vein Thrombosis (DVT)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Pulmonary Embolism (PE)
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Homecare Settings
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Ambulatory Surgical Centers
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast
  • 10.5 Others
    • 10.5.1 Market Trends
    • 10.5.2 Market Forecast

11 Market Breakup by Distribution Channel

  • 11.1 Hospital Pharmacies
    • 11.1.1 Market Trends
    • 11.1.2 Market Forecast
  • 11.2 Retail Pharmacies
    • 11.2.1 Market Trends
    • 11.2.2 Market Forecast
  • 11.3 Drug Stores
    • 11.3.1 Market Trends
    • 11.3.2 Market Forecast
  • 11.4 Online Stores
    • 11.4.1 Market Trends
    • 11.4.2 Market Forecast
  • 11.5 Others
    • 11.5.1 Market Trends
    • 11.5.2 Market Forecast

12 Market Breakup by Region

  • 12.1 Europe
    • 12.1.1 Market Trends
    • 12.1.2 Market Forecast
  • 12.2 North America
    • 12.2.1 Market Trends
    • 12.2.2 Market Forecast
  • 12.3 Asia Pacific
    • 12.3.1 Market Trends
    • 12.3.2 Market Forecast
  • 12.4 Middle East and Africa
    • 12.4.1 Market Trends
    • 12.4.2 Market Forecast
  • 12.5 Latin America
    • 12.5.1 Market Trends
    • 12.5.2 Market Forecast

13 SWOT Analysis

  • 13.1 Overview
  • 13.2 Strengths
  • 13.3 Weaknesses
  • 13.4 Opportunities
  • 13.5 Threats

14 Value Chain Analysis

15 Porter's Five Forces Analysis

  • 15.1 Overview
  • 15.2 Bargaining Power of Buyers
  • 15.3 Bargaining Power of Suppliers
  • 15.4 Degree of Competition
  • 15.5 Threat of New Entrants
  • 15.6 Threat of Substitutes

16 Price Analysis

17 Competitive Landscape

  • 17.1 Market Structure
  • 17.2 Key Players
  • 17.3 Profiles of Key Players
    • 17.3.1 GlaxoSmithKline
    • 17.3.2 Hepalink
    • 17.3.3 Pfizer
    • 17.3.4 LeoPharma
    • 17.3.5 Sanofi
    • 17.3.6 Dr. Reddy's Laboratories
    • 17.3.7 Teva Pharmaceutical Industries
    • 17.3.8 Aspen
    • 17.3.9 LEO Pharma
    • 17.3.10 Baxter
    • 17.3.11 Changshan Pharm
    • 17.3.12 Sandoz
    • 17.3.13 Opocrin
    • 17.3.14 Deebio
    • 17.3.15 Tiandong

List of Figures

  • Figure 1: Global: Heparin Market: Major Drivers and Challenges
  • Figure 2: Global: Heparin Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Heparin Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Heparin Market: Breakup by Source (in %), 2020
  • Figure 5: Global: Heparin Market: Breakup by Mode of Administration (in %), 2020
  • Figure 6: Global: Heparin Market: Breakup by Application (in %), 2020
  • Figure 7: Global: Heparin Market: Breakup by End-User (in %), 2020
  • Figure 8: Global: Heparin Market: Breakup by Distribution Channel (in %), 2020
  • Figure 9: Global: Heparin Market: Breakup by Region (in %), 2020
  • Figure 10: Global: Heparin Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 11: Global: Heparin Industry: SWOT Analysis
  • Figure 12: Global: Heparin Industry: Value Chain Analysis
  • Figure 13: Global: Heparin Industry: Porter's Five Forces Analysis
  • Figure 14: Global: Heparin (Unfractionated Heparin) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 15: Global: Heparin (Unfractionated Heparin) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 16: Global: Heparin (Low Molecular Weight Heparin) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 17: Global: Heparin (Low Molecular Weight Heparin) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 18: Global: Heparin (Ultra-Low Molecular Weight Heparin) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 19: Global: Heparin (Ultra-Low Molecular Weight Heparin) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 20: Global: Heparin (Bovine) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 21: Global: Heparin (Bovine) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 22: Global: Heparin (Porcine) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 23: Global: Heparin (Porcine) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 24: Global: Heparin (Oral) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 25: Global: Heparin (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 26: Global: Heparin (Parenteral) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 27: Global: Heparin (Parenteral) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 28: Global: Heparin (Atrial Fibrillation & Heart Attack) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 29: Global: Heparin (Atrial Fibrillation & Heart Attack) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 30: Global: Heparin (Stroke) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 31: Global: Heparin (Stroke) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 32: Global: Heparin (Deep Vein Thrombosis) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 33: Global: Heparin (Deep Vein Thrombosis) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 34: Global: Heparin (Pulmonary Embolism) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 35: Global: Heparin (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 36: Global: Heparin (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 37: Global: Heparin (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 38: Global: Heparin (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 39: Global: Heparin (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 40: Global: Heparin (Clinics) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 41: Global: Heparin (Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 42: Global: Heparin (Homecare Settings) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 43: Global: Heparin (Homecare Settings) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 44: Global: Heparin (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 45: Global: Heparin (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 46: Global: Heparin (Other End-Users) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 47: Global: Heparin (Other End-Users) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 48: Global: Heparin Market: Sales through Hospital Pharmacies (in Million US$), 2015 & 2020
  • Figure 49: Global: Heparin Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2021-2026
  • Figure 50: Global: Heparin Market: Sales through Retail Pharmacies (in Million US$), 2015 & 2020
  • Figure 51: Global: Heparin Market Forecast: Sales through Retail Pharmacies (in Million US$), 2021-2026
  • Figure 52: Global: Heparin Market: Sales through Drug Stores (in Million US$), 2015 & 2020
  • Figure 53: Global: Heparin Market Forecast: Sales through Drug Stores (in Million US$), 2021-2026
  • Figure 54: Global: Heparin Market: Sales through Online Stores (in Million US$), 2015 & 2020
  • Figure 55: Global: Heparin Market Forecast: Sales through Online Stores (in Million US$), 2021-2026
  • Figure 56: Global: Heparin Market: Sales through Other Distribution Channels (in Million US$), 2015 & 2020
  • Figure 57: Global: Heparin Market Forecast: Sales through Other Distribution Channels (in Million US$), 2021-2026
  • Figure 58: Europe: Heparin Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 59: Europe: Heparin Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 60: North America: Heparin Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 61: North America: Heparin Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 62: Asia Pacific: Heparin Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 63: Asia Pacific: Heparin Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 64: Middle East and Africa: Heparin Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 65: Middle East and Africa: Heparin Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 66: Latin America: Heparin Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 67: Latin America: Heparin Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Heparin Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Heparin Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Heparin Market Forecast: Breakup by Source (in Million US$), 2021-2026
  • Table 4: Global: Heparin Market Forecast: Breakup by Mode of Administration (in Million US$), 2021-2026
  • Table 5: Global: Heparin Market Forecast: Breakup by Application (in Million US$), 2021-2026
  • Table 6: Global: Heparin Market Forecast: Breakup by End-User (in Million US$), 2021-2026
  • Table 7: Global: Heparin Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
  • Table 8: Global: Heparin Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 9: Global: Heparin Market Structure
  • Table 10: Global: Heparin Market: Key Players